Literature DB >> 34094786

Type I Gastric Neuroendocrine Tumor Presenting as Acute Upper Gastrointestinal Bleed.

Anusha Bapatla1, Ameena Syed1, Abu Fazal Shaik Mohammed1, Cortney V Jones2, Rana Ismail1.   

Abstract

Gastric neuroendocrine tumors (GNETs) are rare and subdivided into type I, type II, and type III. Types I and II are gastrin-dependent and are usually benign, whereas type III is gastrin-independent and more aggressive. Type I accounts for 70-80% of all GNETs. Most of them are asymptomatic and incidentally detected on endoscopy. It can sometimes present with iron and B12 deficiency, dyspepsia, and less commonly with an upper GI bleed. We present a case of type I GNET who came to the hospital with melena and esophagogastroduodenoscopy (EGD) showing a 3-cm bleeding polyp and histopathology revealing a well-differentiated neuroendocrine tumor with angioinvasion.
Copyright © 2021, Bapatla et al.

Entities:  

Keywords:  chronic atrophic gastritis; enterochromaffin like cells; gastric neuroendocrine tumors; pernicious anemia; type 1 gastric neuroendocrine tumors

Year:  2021        PMID: 34094786      PMCID: PMC8172005          DOI: 10.7759/cureus.15343

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  17 in total

1.  Tumour type and size are prognostic factors in gastric neuroendocrine neoplasia: A multicentre retrospective study.

Authors:  Francesco Panzuto; Davide Campana; Sara Massironi; Antongiulio Faggiano; Maria Rinzivillo; Giuseppe Lamberti; Valentina Sciola; Edith Lahner; Lisa Manuzzi; Annamaria Colao; Bruno Annibale
Journal:  Dig Liver Dis       Date:  2019-06-05       Impact factor: 4.088

Review 2.  Current concepts in the diagnosis and management of type 1 gastric neuroendocrine neoplasms.

Authors:  Gregory Kaltsas; Simona Grozinsky-Glasberg; Krystallenia I Alexandraki; Dimitrios Thomas; Apostolos V Tsolakis; David Gross; Ashley B Grossman
Journal:  Clin Endocrinol (Oxf)       Date:  2014-05-26       Impact factor: 3.478

Review 3.  Autoimmune metaplastic atrophic gastritis and association with neuroendocrine tumors of the stomach.

Authors:  Fredy Nehme; Kyle Rowe; William Palko; Nathan Tofteland; William Salyers
Journal:  Clin J Gastroenterol       Date:  2019-11-28

4.  Clinical Outcomes of Endoscopic Treatment for Type 1 Gastric Neuroendocrine Tumor.

Authors:  Jin Hee Noh; Do Hoon Kim; Hwan Yoon; Li-Chang Hsing; Hee Kyong Na; Ji Yong Ahn; Jeong Hoon Lee; Kee Wook Jung; Kee Don Choi; Ho June Song; Gin Hyug Lee; Hwoon-Yong Jung
Journal:  J Gastrointest Surg       Date:  2021-04-06       Impact factor: 3.452

5.  Recurrence and metastatic potential in Type 1 gastric neuroendocrine neoplasms.

Authors:  Kosmas Daskalakis; Marina Tsoli; Angeliki Karapanagioti; Maria Chrysochoou; Dimitrios Thomas; Stavros Sougioultzis; Ioannis Karoumpalis; Gregory A Kaltsas; Krystallenia I Alexandraki
Journal:  Clin Endocrinol (Oxf)       Date:  2019-07-07       Impact factor: 3.478

6.  Total gastrectomy for type 1 gastric carcinoid: an unusual surgical indication?

Authors:  G Clemente; G Sarno; M Giordano; A M De Rose; I Giovannini; F M Vecchio; G Nuzzo
Journal:  Minerva Chir       Date:  2007-10       Impact factor: 1.000

7.  Prognosis of gastric carcinoid tumours.

Authors:  S Rappel; A Altendorf-Hofmann; M Stolte
Journal:  Digestion       Date:  1995       Impact factor: 3.216

8.  Long-term results of endoscopic resection for type I gastric neuroendocrine tumors.

Authors:  Ahmet Uygun; Abdurrahman Kadayifci; Zulfikar Polat; Kemalettin Yilmaz; Armagan Gunal; Hakan Demir; Sait Bagci
Journal:  J Surg Oncol       Date:  2013-10-25       Impact factor: 3.454

9.  TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.

Authors:  G Rindi; G Klöppel; H Alhman; M Caplin; A Couvelard; W W de Herder; B Erikssson; A Falchetti; M Falconi; P Komminoth; M Körner; J M Lopes; A-M McNicol; O Nilsson; A Perren; A Scarpa; J-Y Scoazec; B Wiedenmann
Journal:  Virchows Arch       Date:  2006-09-12       Impact factor: 4.064

10.  Gastric neuroendocrine neoplasms type 1: A systematic review and meta-analysis.

Authors:  Apostolos V Tsolakis; Athanasia Ragkousi; Miroslav Vujasinovic; Gregory Kaltsas; Kosmas Daskalakis
Journal:  World J Gastroenterol       Date:  2019-09-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.